UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene

The American journal of pathology, 2014, Vol.184 (9), p.2420-2429

2014

Volltextzugriff (PDF)

Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?

Multiple sclerosis, 2010-01, Vol.16 (1), p.55-61

2010

Volltextzugriff (PDF)

Value of NMO-IgG determination at the time of presentation as CIS

Neurology, 2012-05, Vol.78 (20), p.1608-1611

2012

Volltextzugriff (PDF)

TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients

Journal of neuroimmunology, 2013-08, Vol.261 (1), p.146-148

2013

Volltextzugriff (PDF)

Cellular immune responses in multiple sclerosis patients treated with interferon‐beta

Clinical and experimental immunology, 2013-03, Vol.171 (3), p.243-246

2013

Volltextzugriff (PDF)

Treatment with interferon-beta does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients

Journal of neuroimmunology, 2013-02, Vol.255 (1), p.102-104

2013

Volltextzugriff (PDF)

Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis

Journal of neuroimmunology, 2012-04, Vol.245 (1), p.98-101

2012

Volltextzugriff (PDF)

Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis

Genes and immunity, 2011-09, Vol.12 (6), p.466-472

2011

Volltextzugriff (PDF)

Replication of top markers of a genome-wide association study in multiple sclerosis in Spain

Genes and immunity, 2011-03, Vol.12 (2), p.110-115

2011

Volltextzugriff (PDF)

Neutralising antibodies to interferon β in multiple sclerosis : Expert panel report

Journal of neurology, 2007-07, Vol.254 (7), p.827-837

2007

Volltextzugriff (PDF)

Neurofilaments as biomarkers in neurological disorders - towards clinical application

Nature reviews. Neurology, 2024-05, Vol.20 (5), p.269-287

2024

Volltextzugriff (PDF)

HLA class I and II alleles and response to treatment with interferon-beta in relapsing–remitting multiple sclerosis

Journal of neuroimmunology, 2009-05, Vol.210 (1), p.116-119

2009

Volltextzugriff (PDF)

Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS

Journal of neurology, 2010-05, Vol.257 (5), p.742-746

2010

Volltextzugriff (PDF)

Decision tree based fuzzy classifier of magnetic resonance spectra from cerebrospinal fluid samples

Fuzzy sets and systems, 2011-05, Vol.170 (1), p.43-63

2011

Volltextzugriff (PDF)

IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis

Journal of neuroimmunology, 2011-10, Vol.239 (1), p.101-104

2011

Volltextzugriff (PDF)

W1.2 Multifocal motor neuropathy. Clinical and electrophysiological long term evolution in a group of patients

Clinical neurophysiology, 2011, Vol.122, p.S6-S7

2011

Volltextzugriff (PDF)

Plasma chitotriosidase activity in multiple sclerosis

Clinical immunology (Orlando, Fla.), 2009-05, Vol.131 (2), p.216-222

2009

Volltextzugriff (PDF)

Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis

Journal of neurology, 2008-08, Vol.255 (8), p.1136-1141

2008

Volltextzugriff (PDF)

Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis

Journal of neuroimmunology, 2010-05, Vol.222 (1), p.70-75

2010

Volltextzugriff (PDF)

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

PLoS medicine, 2020-10, Vol.17 (10), p.e1003348

2020

Volltextzugriff (PDF)

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

Brain (London, England : 1878), 2015-04, Vol.138 (Pt 4), p.918-931

2015

Volltextzugriff (PDF)

Antiviral immune response in patients with multiple sclerosis and healthy siblings

Multiple sclerosis, 2010-03, Vol.16 (3), p.355-358

2010

Volltextzugriff (PDF)

Multiple sclerosis: current treatment algorithms

Current opinion in neurology, 2011-06, Vol.24 (3), p.230-237

2011

Volltextzugriff (PDF)

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

Annals of neurology, 2006-02, Vol.59 (2), p.344-352

2006

Volltextzugriff (PDF)

26 – 50 von 282

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(248)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene

Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?

Value of NMO-IgG determination at the time of presentation as CIS

TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients

Cellular immune responses in multiple sclerosis patients treated with interferon‐beta

Treatment with interferon-beta does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients

Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis

Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis

Replication of top markers of a genome-wide association study in multiple sclerosis in Spain

Neutralising antibodies to interferon β in multiple sclerosis : Expert panel report

Neurofilaments as biomarkers in neurological disorders - towards clinical application

HLA class I and II alleles and response to treatment with interferon-beta in relapsing–remitting multiple sclerosis

Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS

Decision tree based fuzzy classifier of magnetic resonance spectra from cerebrospinal fluid samples

IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis

W1.2 Multifocal motor neuropathy. Clinical and electrophysiological long term evolution in a group of patients

Plasma chitotriosidase activity in multiple sclerosis

Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis

Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

Antiviral immune response in patients with multiple sclerosis and healthy siblings

Multiple sclerosis: current treatment algorithms

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

Suchergebnisse filtern